Adoption of Ultrahypofractionated Radiation Therapy in Patients With Breast Cancer

INTRODUCTION: The first high-quality clinical trial to support ultrahypofractionated whole-breast irradiation (ultra-HF-WBI) for invasive early-stage breast cancer (ESBC) was published in April 2020, coinciding with the beginning of the COVID-19 pandemic. We analyzed adoption of ultra-HF-WBI for duc...

Descripción completa

Detalles Bibliográficos
Autores principales: Corrigan, Kelsey L., Lei, Xiudong, Ahmad, Neelofur, Arzu, Isidora, Bloom, Elizabeth, Chun, Stephen G., Goodman, Chelain, Hoffman, Karen E., Joyner, Melissa, Mayo, Lauren, Mitchell, Melissa, Nead, Kevin T., Perkins, George H., Reed, Valerie, Reddy, Jay P., Schlembach, Pamela, Shaitelman, Simona F., Stauder, Michael C., Strom, Eric A., Tereffe, Welela, Wiederhold, Lee, Woodward, Wendy A., Smith, Benjamin D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Scientific Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8977907/
https://www.ncbi.nlm.nih.gov/pubmed/35387420
http://dx.doi.org/10.1016/j.adro.2021.100877

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8977907/
https://www.ncbi.nlm.nih.gov/pubmed/35387420
http://dx.doi.org/10.1016/j.adro.2021.100877

Ejemplares similares